Showing results (41-50 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|April 1, 2017
Redox Biotransformation and Delivery of Anthracycline Anticancer Antibiotics: How Interpretable Structure-activity Relationships of Lethality Using Electrophilicity and the London Formula for Dispersion Interaction WorkSiu-Kwong PangCurrent Cancer Drug Targets|April 1, 2017
Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M MutantsSubhash Mohan Agarwal, Divyani Pal, Mansi Gupta, et al.Current Cancer Drug Targets|November 12, 2016
Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An In Silico ApproachFarzaneh Mohamadi Farsani, Mohamad Reza Ganjalikhany, Sadeq VallianCurrent Cancer Drug Targets|September 19, 2019
ERGIC3 Silencing Additively Enhances the Growth Inhibition of BFA on Lung Adenocarcinoma CellsQiurong Zhao, Mingsong Wu, Xiang Zheng, et al.Current Cancer Drug Targets|October 3, 2019
Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with MetastasisNikolai V Litviakov, Marina K Ibragimova, Matvey M Tsyganov, et al.Current Cancer Drug Targets|February 17, 2021
Cross Talk between COVID-19 and Breast CancerHamendra Singh Parmar, Aakruti Nayak, Pramod Kumar Gavel, et al.Current Cancer Drug Targets|March 3, 2021
Association of Polymorphism in Survivin Gene and the Risk of Liver Cancer Resulting from Hepatitis C Virus Among Egyptian PatientsAmal A Mohamed, Aymen S Yassin, Basma S Gomaa, et al.Current Cancer Drug Targets|February 4, 2021
Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer TherapyMilad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, et al.Current Cancer Drug Targets|December 8, 2004
Proline-directed protein kinase FA as a potential target for diagnosis and therapy of human cancersShiaw-Der YangCurrent Cancer Drug Targets|December 20, 2003
Hypoxia inducible factor as a cancer drug targetSarah J Welsh, Garth PowisPageof 187